Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders.
Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis.
Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
Impact of oral health in patients with multiple sclerosis and epilepsy: A survey in a neurology clinic.
Blood pressure normalization post-jugular venous balloon angioplasty.
Advancing drug delivery systems for the treatment of multiple sclerosis.
Cannabinoid modulation of neuroinflammatory disorders.
MicroRNA in neurodegenerative drug discovery: the way forward?
Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.
Galectin-9 is Up-regulated in Astrocytes by TNF and Promotes Encephalitogenic T-cell Apoptosis.
A case of tumor-like inflammatory demyelinating disease with progressive brain and spinal cord involvement.
Amino Acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors.
Bedside tested ocular motor disorders in multiple sclerosis patients.
Cytokines and chemokines in multiple sclerosis.
BAFF maintains T-cell survival by inducing OPN expression in B cells.
CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients.
Immune-regulatory mechanisms of classical and experimental multiple sclerosis drugs: special focus on helminth-derived treatments.
Patients with neuromuscular disorder.
Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices.
Inhibition of Epidermal Growth Factor Receptor Improves Myelination and Attenuates Tissue Damage of Spinal Cord Injury.
Natalizumab and multiple sclerosis.
The Roles of Egr-2 in Autoimmune Diseases.
Expression of Lymphatic Markers in the Adult Rat Spinal Cord.
Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study.
Pages
« first
‹ previous
…
455
456
457
458
459
460
461
462
463
…
next ›
last »